Literature DB >> 7097002

Hepatitis B virus infection in prisons. A seroepidemiological survey in prisoners and attending staff.

M Chiaramonte, R Trivello, G Renzulli, L Zampieri, A Fanecco, A Floreani, R Naccarato.   

Abstract

Prisoners and attending staff from six houses of detention were screened for serum HBsAg, anti HBs, antiHBc and transaminases. Both prisoners and warders showed an increased prevalence of HBV serum markers with respect to age- and sex-matched general population control groups. The HBsAg carrier rate was 6.7% in prisoners and 6.6% in staff. Sixty-five per cent of the HBsAg-positive subjects were antiHBe-positive. When the blood samples were taken, all the HBsAg-positive subjects were asymptomatic; transaminases were normal in 80% and only slightly elevated in 20%. Illicit drug abuse was found to be a relevant risk factor for HBV infection among prisoners under 35 yearts of age, but not in the older group, whereas no correlation emerged between presence of HBV serum markers and tattoos or admitted homosexuality. A high prevalance of HBV serum markers as also found among young warders who had been in service for a short time: most of them, however, come from areas of Italy with a particularly elevated HBV circulation. Although the results suggest that many of the HBV infections are not recently acquired within the institution, this survey confirms that prisons should be regarded as high risk areas for HBV infection, both for prisoners and warders.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7097002      PMCID: PMC2134178          DOI: 10.1017/s0022172400070534

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  11 in total

1.  On the role of sexual behavior in the spread of hepatitis B infection.

Authors:  W Szmuness; I Much; A M Prince; J H Hoofnagle; C E Cherubin; E J Harley; G H Block
Journal:  Ann Intern Med       Date:  1975-10       Impact factor: 25.391

2.  Hepatitis B e antigen and infectivity of hepatitis B virus.

Authors:  T Shikata; T Karasawa; K Abe; T Uzawa; H Suzuki; T Oda; M Imai; M Mayumi; Y Moritsugu
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

3.  The epidemiology of serum hepatitis (SH) infections: a controlled study in two closed institutions.

Authors:  W Szmuness; A M Prince
Journal:  Am J Epidemiol       Date:  1971-12       Impact factor: 4.897

4.  The incidence of Australia antigen and antibody in male prisoners of two Sydney penitentiaries.

Authors:  P G Watson; J R Watts; M Nelson
Journal:  Med J Aust       Date:  1973-09-01       Impact factor: 7.738

5.  Hepatitis with Australia antigen after tattooing.

Authors:  G Sterner; B O Agell; P Gerzén; R Berg
Journal:  Scand J Infect Dis       Date:  1971

6.  Australia antigen in volunteer and paid blood donors.

Authors:  A Kliman
Journal:  N Engl J Med       Date:  1971-01-14       Impact factor: 91.245

7.  Au antigen in blood from prisoners.

Authors:  F J Muniz; H Malyska; W C Levin
Journal:  N Engl J Med       Date:  1971-03-04       Impact factor: 91.245

8.  Prevalence of hepatitis B surface antigen and antibody at a state prison in Kansas.

Authors:  J P Koplan; J A Walker; J A Bryan; K R Berquist
Journal:  J Infect Dis       Date:  1978-04       Impact factor: 5.226

9.  Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure.

Authors:  H J Alter; L B Seeff; P M Kaplan; V J McAuliffe; E C Wright; J L Gerin; R H Purcell; P V Holland; H J Zimmerman
Journal:  N Engl J Med       Date:  1976-10-21       Impact factor: 91.245

10.  Prevalence of hepatitis B antigen and antibody in prostitutes.

Authors:  G Papaevangelou; D Trichopoulos; T Kremastinou; G Papoutsakis
Journal:  Br Med J       Date:  1974-05-04
View more
  10 in total

1.  Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary.

Authors:  Bálint Tresó; Erzsébet Barcsay; Anna Tarján; Gergely Horváth; Agnes Dencs; Andrea Hettmann; Mária Magdolna Csépai; Zoltán Gyori; Erzsébet Rusvai; Mária Takács
Journal:  J Urban Health       Date:  2012-02       Impact factor: 3.671

2.  Analysis of risk factors associated with hepatitis B and C infection in correctional institutions in British Columbia.

Authors:  R Préfontaine; R Chaudhary; R Mathias
Journal:  Can J Infect Dis       Date:  1994-07

3.  Evidence for gonococcal transmission within a correctional system.

Authors:  K H van Hoeven; W C Rooney; S C Joseph
Journal:  Am J Public Health       Date:  1990-12       Impact factor: 9.308

4.  Prevalence of markers for hepatitis B and hepatitis D in a municipal house of correction.

Authors:  M A Barry; D Gleavy; K Herd; P J Schwingl; B G Werner
Journal:  Am J Public Health       Date:  1990-04       Impact factor: 9.308

5.  Transmission of infectious diseases in prison.

Authors:  C Matheï; P van Damme; A Meheus
Journal:  BMJ       Date:  1993-11-06

6.  Should prisoners be immunized against hepatitis B?

Authors:  M D Decker; W Schaffrer
Journal:  Am J Public Health       Date:  1985-10       Impact factor: 9.308

7.  Prevalence of hepatitis B infection in long-stay mentally handicapped adults.

Authors:  F Asensio; J M Bayas; M J Bertran; M A Asenjo
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

8.  Hepatitis B in Wisconsin male prisoners: considerations for serologic screening and vaccination.

Authors:  R F Anda; S B Perlman; D J D'Alessio; J P Davis; V N Dodson
Journal:  Am J Public Health       Date:  1985-10       Impact factor: 9.308

9.  Risk of COVID-19 infection among prison staff in the United States.

Authors:  Kathryn M Nowotny; Kapriske Seide; Lauren Brinkley-Rubinstein
Journal:  BMC Public Health       Date:  2021-06-02       Impact factor: 3.295

10.  Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study.

Authors:  Andrew A Adjei; Henry B Armah; Foster Gbagbo; William K Ampofo; Isaac Boamah; Clement Adu-Gyamfi; Isaac Asare; Ian F A Hesse; George Mensah
Journal:  BMC Infect Dis       Date:  2008-03-07       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.